Risks for REATA PHARMACEUTICALS INC (RETA)

Here are some interesting risks from the recent filings of REATA PHARMACEUTICALS INC. Our algorithms work hard to highlight risks unique to this company.

II, Item 7 entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and in any doc

uments incorporated in this Annual Report on Form 10-K by reference, before deciding whether to invest in our Class A common stock. The occurrence of any of the events or developments described below could harm our business, financial condition, results o

f operations, and growth prospects. In such an event, the market price of our Class A common stock could decline, and you may lose all or part of your investment. Although we have discussed all known material risks, the risks described below are not the

only ones that we may face. Additional risks and uncertainties not currently known to us or that we currently deem immaterial may also impair our business operations. Certain statements below are forward-looking statements. See also “Special Note Regard

Our product candidates may cause or have attributed to them undesirable side effects or have other properties that delay or pre